









Mercado
/
Acciones
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

6.090USD

+0.210+3.57%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

284.30MCap. mercado

PérdidaP/E TTM



Quanterix Corp

6.090

+0.210+3.57%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Quanterix Corp Compañía

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Información de Quanterix Corp



Símbolo de cotizaciónQTRX

Nombre de la empresaQuanterix Corp

Fecha de salida a bolsaDec 07, 2017

Director ejecutivoToloue (Masoud)

Número de empleados471

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 07

Dirección900 Middlesex Turnpike

CiudadBILLERICA

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal01821

Teléfono16173019400

Sitio Webhttps://www.quanterix.com/

Símbolo de cotizaciónQTRX

Fecha de salida a bolsaDec 07, 2017

Director ejecutivoToloue (Masoud)

Ejecutivos de Quanterix Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.95K

-4395.00%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Dr. Garret Hampton, Ph.D.

Independent Director

Dr. Alan Sachs, M.D., Ph.D.

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

Desglose de ingresos

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

Por regiónUSD

Nombre

Ganancia

Proporción

North America

24.39M

0.00%

EMEA

11.08M

0.00%

Asia Pacific

4.68M

0.00%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

Estadísticas de accionistas

Actualizado: vie., 21 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

Otro

66.95%

Accionistas

Proporción

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

Otro

66.95%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

37.10%

Investment Advisor

22.29%

Hedge Fund

12.26%

Individual Investor

6.30%

Private Equity

5.36%

Research Firm

4.36%

Pension Fund

0.44%

Bank and Trust

0.20%

Family Office

0.13%

Otro

11.56%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

383

38.26M

81.91%

-7.44M

2025Q3

384

34.11M

73.41%

-9.53M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Portolan Capital Management, L.L.C.

4.26M

9.12%

+626.23K

+17.23%

Sep 30, 2025

Columbia Threadneedle Investments (UK)

3.14M

6.71%

+8.77K

+0.28%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.86M

6.12%

+212.22K

+8.01%

Sep 30, 2025

The Vanguard Group, Inc.

2.65M

5.67%

+118.56K

+4.69%

Sep 30, 2025

Telegraph Hill Partners

2.50M

5.36%

+2.50M

Sep 30, 2025

Walt (David R)

1.86M

3.99%

+2.59K

+0.14%

Oct 01, 2025

Invenomic Capital Management LP

1.39M

2.98%

+248.10K

+21.67%

Sep 30, 2025

William Blair Investment Management, LLC

1.32M

2.82%

+187.30K

+16.60%

Sep 30, 2025

Easterly Investment Partners LLC

1.25M

2.68%

+168.55K

+15.55%

Sep 30, 2025

Millennium Management LLC

1.21M

2.59%

+1.20M

+9880.18%

Sep 30, 2025

ETFs relacionados



Actualizado: mar., 2 de dic

Nombre

Proporción

Invesco NASDAQ Future Gen 200 ETF

0.63%

iShares Micro-Cap ETF

0.04%

Fidelity Enhanced Small Cap ETF

0.03%

Avantis US Small Cap Equity ETF

0.03%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

iShares Biotechnology ETF

0.02%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.63%

iShares Micro-Cap ETF

Proporción0.04%

Fidelity Enhanced Small Cap ETF

Proporción0.03%

Avantis US Small Cap Equity ETF

Proporción0.03%

Invesco RAFI US 1500 Small-Mid ETF

Proporción0.02%

iShares Biotechnology ETF

Proporción0.02%

Proshares Ultra Russell 2000

Proporción0.01%

ProShares UltraPro Russell2000

Proporción0.01%

iShares Russell 2000 Value ETF

Proporción0.01%

Global X Russell 2000 ETF

Proporción0.01%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

